Skip to main content
NIH funding notice RFA-AI-24-025

Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)

Closed on October 9, 2024.

Posted
April 25, 2024
Close date
October 9, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,456,919 in first-year total cost, median $1,285,304.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 RCU-A (M1)]3

Most frequent institutions

  1. SCRIPPS RESEARCH INSTITUTE, THE2
  2. DUKE UNIVERSITY1
Competing awards under RFA-AI-24-025 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development1R01AI192456-01BRINEY, BRYANSCRIPPS RESEARCH INSTITUTE, THE, CA$1,379,954ZAI1
2025Enhancing durability of V3 glycan vaccine responses in rhesus macaques1R01AI192458-01STEICHEN, JONSCRIPPS RESEARCH INSTITUTE, THE, CA$1,285,304ZAI1
2025Persistent Immunogenicity of IDLV delivering Gag and membrane tethered HIV-1 Envelope Trimers1R01AI192378-01BLASI, MARIAWILLIAMS, WILTON BDUKE UNIVERSITY, NC$791,661ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.